Another functional test found to be useful in diagnosing and monitoring the course of ABPA before and after treatment is thymus and activation-regulated chemokine (TARC), whose serum levels are higher in ABPA patients and decrease after therapy [53]. The gene discussed is CCL17; the disease is allergic bronchopulmonary aspergillosis.